Live Breaking News & Updates on Prnewswire Willow Biosciences Inc

Stay updated with breaking news from Prnewswire willow biosciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION

WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Chris Savile , Daniel Rivero , Prnewswire Willow Biosciences Inc , Manufacturing Organization , Health Wellness , Contract Development , Biosciences Inc , Active Pharmaceutical Ingredient , Industrial Director , Technology Transfer ,

Willow Biosciences Advances Its Work On THC; Plans To Launch In The [...]

19 gennaio 2021 13:02
Fonte: Adnkronos
#altro
VANCOUVER, BC, Jan. 19, 2021 /PRNewswire/ Willow Biosciences Inc. ( Willow or the Company ) (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has advanced its work on its proprietary yeast strain for production of Tetrahydrocannabinol ( THC ), and plans to commercially launch in the Canadian market.
We are excited to announce our proprietary THC yeast biosynthesis production process for launch in the Canadian market, said Trevor Peters, Willow s President and Chief Executive Officer. Our platform technology enables us to produce a variety of cannabinoids and leverage our previous work on CBG. From conversations with prospective customers in Canada, we believe that there is significant demand for consistent, high-purity THC. The flavourless, odorless attributes of our finished product make it suitable as a core ingredient for the cannabis 2.0 market in Canada. There is also strong demand for a more sus ....

United States , United Kingdom , British Columbia , Troy Talkkari , Trevor Peters , Willow Biosciences Inc , Corporate Development , Prnewswire Willow Biosciences Inc , Company Canadian , Chief Executive , Willow Biosciences , Looking Statements This , Chief Executive Officer , Vice President , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , ட்ரெவர் பீட்டர்ஸ் , வில்லோ உயிர் அறிவியல் இன்க் , பெருநிறுவன வளர்ச்சி , நிறுவனம் கனடியன் , தலைமை நிர்வாகி , வில்லோ உயிர் அறிவியல் , பார்க்கிறது அறிக்கைகள் இது , தலைமை நிர்வாகி அதிகாரி , துணை ப்ரெஸிடெஂட் ,

Willow Biosciences Advances Its Work On THC; Plans To Launch In The Canadian Market

Willow Biosciences Advances Its Work On THC; Plans To Launch In The Canadian Market
19 gennaio 2021 | 13.01
LETTURA: 5 minuti
VANCOUVER, BC, Jan. 19, 2021 /PRNewswire/ Willow Biosciences Inc. ( Willow or the Company ) (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has advanced its work on its proprietary yeast strain for production of Tetrahydrocannabinol ( THC ), and plans to commercially launch in the Canadian market.
We are excited to announce our proprietary THC yeast biosynthesis production process for launch in the Canadian market, said Trevor Peters, Willow s President and Chief Executive Officer. Our platform technology enables us to produce a variety of cannabinoids and leverage our previous work on CBG. From conversations with prospective customers in Canada, we believe that there is significant demand for consistent, high-purity THC. The flavourless, odorless attributes of our finished product make it ....

United States , United Kingdom , British Columbia , Troy Talkkari , Trevor Peters , Willow Biosciences Inc , Corporate Development , Prnewswire Willow Biosciences Inc , Company Canadian , Chief Executive , Chief Executive Officer , Vice President , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , ட்ரெவர் பீட்டர்ஸ் , வில்லோ உயிர் அறிவியல் இன்க் , பெருநிறுவன வளர்ச்சி , நிறுவனம் கனடியன் , தலைமை நிர்வாகி , தலைமை நிர்வாகி அதிகாரி , துணை ப்ரெஸிடெஂட் ,